Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Trial abstract · §3

REDEFINE-1-ELDERLY — results

Primary endpoint, absolute and relative effect where derivable, and harms as reported.

Document identifier
CEI-TR-0459/3
Series
Trial abstract
Version
1.0
Published
15 Feb 2025
Last reviewed
15 Feb 2026
Next review
15 Feb 2028
Identifier
10.71829/cei.trial.459
Certainty
Very low
Cycle
2025 Q1
Phase
Phase 3
Status
Reported

Institute-constructed programme record. This document is not a report of a published trial. It is a record the Institute has constructed to represent an instalment, sub-study or extension of a real development programme, published in order to carry a methodological point that the parent trial report does not address. No effect estimate on this page is attributable to any publication, and its reference-list entry carries a programme-record label rather than a citation. The policy governing these records was settled through a public comment period.

§3Results

§3.1Primary endpoint

Table 3. Primary endpoint as reported.

EndpointResult as reportedCertainty
Primary endpoint of the parent trial in participants aged 65 years and aboveno result held by the InstituteVery low
The Institute publishes no effect estimate for a trial whose report it does not hold.

§3.2Harms as reported

No adverse-event table is held for this record. An absence of reported harms is not a finding that none occurred.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.